REQUEST A DEMO
Total
USD $0.00
Search more companies

Medifar Sp. z o.o. sp. k. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Medifar Sp. z o.o. sp. k. Profile Updated: July 20, 2021
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Medifar Sp. z o.o. sp. k. is based in Poland. The head office is in Warsaw. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on January 10, 2020. The company’s latest financial report indicates a net sales revenue increase of 87.02% in 2020. A growth of 198.16% was recorded in its total assets. The net profit margin of Medifar Sp. z o.o. sp. k. increased by 25.15% in 2020.

Headquarters
Ul. Franciszka Klimczaka 1
Warsaw; Mazowieckie; Postal Code: 02-797

Contact Details: Purchase the Medifar Sp. z o.o. sp. k. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medifar Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
January 10, 2020
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Medifar Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
87.02%
Total operating revenue
74.05%
Operating profit (EBIT)
1355.44%
EBITDA
1067.6%
Net Profit (Loss) for the Period
2331.77%
Total assets
198.16%
Total equity
1279.65%
Operating Profit Margin (ROS)
23.73%
Net Profit Margin
25.15%
Return on Equity (ROE)
40.13%
Debt to Equity Ratio
13.81%
Quick Ratio
2.71%
Cash Ratio
0.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?